Composition for enhancing α-galactosidase expression

TW202639120APending Publication Date: 2026-10-01KYOTO UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114112285
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-03-19
Filing Date
2025-03-31
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078035_001
    Figure TWG2TA001078035_001
  • Figure TWG2TA001078035_002
    Figure TWG2TA001078035_002
  • Figure TWG2TA001078035_003
    Figure TWG2TA001078035_003
Patent Text Reader

Abstract

The objective of this invention is to provide a pharmaceutical composition capable of enhancing the expression of α-galactosidase in a single state. This invention relates to a pharmaceutical composition for enhancing the expression of α-galactosidase, comprising a compound represented by formula (1) or (2) below, or a pharmaceutically permissible salt thereof.
Need to check novelty before this filing date? Find Prior Art